Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/17/17 → 3/18/20 |
A Double Blind Randomized Placebo Controlled Trial Evaluating the Efficacy and Safety of Nintedanib Over 52 Weeks in Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)1199
- Chaaban, Said (PI)
- Buch, Ketan (Former PI)